ArticleThe New England journal of medicine2020
Etiologic Index - A Case-Only Measure of
Article in The New England journal of medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- A comprehensive genomic framework for identifying genes predisposing to homologous recombination repair-deficient breast or ovarian cancer.BJC reports · 2026Article
- Article
- Childhood, adolescent, and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriers.Journal of the National Cancer Institute · 2025Article
- Genomic instability in non-breast or ovarian malignancies of individuals with germline pathogenic variants in BRCA1/2.Journal of the National Cancer Institute · 2024Article
- BRCA1 and friends 30 years on.Nature reviews. Genetics · 2024Article
- Li-Fraumeni Syndrome in the Cancer Genomics Era.Journal of the National Cancer Institute · 2021Article
- Paired Tumor-Normal Sequencing Provides Insights Into the TP53-Related Cancer Spectrum in Patients With Li-Fraumeni Syndrome.Journal of the National Cancer Institute · 2021Article
- Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study.Journal of the National Cancer Institute · 2021Article
- Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021Article
- The ten genes for breast (and ovarian) cancer susceptibility.Nature reviews. Clinical oncology · 2021Article
- Differential Activity of PARP Inhibitors inJCO precision oncology · 2021Article
- Building towards Precision Oncology for Pancreatic Cancer: Real-World Challenges and Opportunities.Genes · 2020Review
- Transforming treatment paradigms: Focus on personalized medicine for high-grade serous ovarian cancer.CA: a cancer journal for cliniciansReview
Corrections and comments
- Comment on
Authors and funding
6 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.